WB
Western blot analysis of IGF1 Receptor beta on different lysates with Rabbit anti-IGF1 Receptor beta antibody at 1/2,000 dilution.
Lane 1: HEK-293 cell lysate (20 µg/Lane),
Lane 2: MCF7 cell lysate (20 µg/Lane),
Lane 3: MDA-MB-231 cell lysate (low expression) (20 µg/Lane),
Lane 4: A431 cell lysate (20 µg/Lane),
Lane 5: HepG2 cell lysate (20 µg/Lane),
Lane 6: A549 cell lysate (20 µg/Lane),
Lane 7: HeLa cell lysate (20 µg/Lane),
Lane 8: HUVEC cell lysate (20 µg/Lane),
Lane 9: NIH/3T3 cell lysate (20 µg/Lane),
Lane 10: C2C12 cell lysate (20 µg/Lane),
Lane 11: C6 cell lysate (20 µg/Lane),
Lane 12: Mouse brain tissue lysate (40 µg/Lane),
Lane 13: Rat brain tissue lysate (40 µg/Lane),
Exposure time: 3 minutes;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody at 1/2,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody at 1/50,000 dilution was used for 1 hour at room temperature.
ICC/IF
Immunocytochemistry analysis of NIH/3T3 cells labeling IGF1 Receptor beta with Rabbit anti-IGF1 Receptor beta antibody at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 15 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-IGF1 Receptor beta antibody at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (488) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (594) was used as the secondary antibody at 1/1,000 dilution.